Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00224_DB00656_nanopub.RAuNkIxMxnoiegF6UdKs3e7Cny-5bj4sA0lebJ_Eq4K34#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00224_DB00656 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00224_DB00656 label "DDI between Indinavir and Trazodone - The protease inhibitor, Indinavir, may increase the efficacy/toxicity of Trazodone by inhibiting Trazodone metabolism via CYP3A4. Monitor for changes in Trazodone efficacy/toxicity if Indinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00224_DB00656]" assertion.
- drugbank_resource:DB00224_DB00656 identifier "drugbank_resource:DB00224_DB00656" assertion.
- drugbank_resource:DB00224_DB00656 title "DDI between Indinavir and Trazodone - The protease inhibitor, Indinavir, may increase the efficacy/toxicity of Trazodone by inhibiting Trazodone metabolism via CYP3A4. Monitor for changes in Trazodone efficacy/toxicity if Indinavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB00656 assertion.
- drugbank:DB00224 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB00656 assertion.